New Plant Powers Execution Test — Can Margins Hold?
Vadodara Unit-III came online in early October. Q2 prints just 4 days later. The Street expects solid growth (₹600+ Cr) as the new capacity ramps, but input costs and execution risk loom.
The Setup
Voltamp Transformers reports Q2 FY27 on October 29, 2026 — exactly 22 days after its Vadodara Unit-III (Power Transformers) commenced commercial production on October 7. This quarter is a critical test: can the company maintain its 28% revenue growth trajectory (Q1 was +28% YoY to ₹543.78 Cr) while the new factory ramps? And will input cost pressure, which squeezed operating profit growth to +11% in Q1, persist?
~₹600–650 Cr
On-plan for 23–25% YoY growth; FY27 Street consensus ₹2.5k Cr implies ~₹652 Cr run-rate
18–19.5%
Q1 operating profit growth lagged revenue (11% vs 28%), signaling input-cost headwinds; Q2 FY26 was 19.39%
Strong
Industrial & renewable demand backdrop remains robust; capex guidance ₹90 Cr fresh allocation approved in Q1
A strong Q2 would print revenue of ₹600 Cr or better, with EBITDA margin maintained at 19%+, signaling that input inflation has stabilized and the new plant ramp is executing cleanly. A weak print would show revenue below ₹580 Cr (delayed orders, capacity bottlenecks) and/or margin compression below 18% (input costs, mix degradation, or early-stage inefficiency at the new plant).
On Track?
Voltamp is tracking well for FY27. Q1 delivered ₹543.78 Cr (28% YoY), and the Street consensus for full-year FY27 is ₹2,500 Cr revenue (+15.9% YoY) with ₹327 EPS (+8.3% YoY). This implies remaining three quarters should average ~₹652 Cr, placing Q2 in line if it prints at ₹600–620 Cr. The capex approval (₹90 Cr fresh) for the Vadodara plant ramp suggests management confidence in demand absorption. Margin compression in Q1 (operating profit growth at 11% vs revenue at 28%) is the wild card — if the new facility operates at lower initial yields or input costs remain elevated, FY27 guidance could come under pressure. Watch the commentary on Unit-III yield and cost trajectory closely.
What the Street Says
Since Last Quarter
Jul 7, 2026
59th AGM held; ₹100 per share dividend (1000%) approved for FY26 — signals confidence in capital position
AGM & Dividend
Jul 31, 2026
Revenue ₹543.78 Cr (+28% YoY), operating profit +11%, profit ₹91.2 Cr — margin lag signals input inflation
Q1 FY27 Results
Sep 24, 2026
Insider trading window closed for Q2 results — routine, no promoter/insider activity flagged
Trading Window Closure
Oct 7, 2026
Vadodara plant (Power Transformers) commenced commercial production — first full quarter of ramp in Q2
Unit-III Production Start
Oct 21, 2026
Board meeting Oct 29 to approve Q2 FY27 unaudited results — agenda routine
Board Meeting Notice
Ownership steady: FII 21.53%, DII 33.85%, promoter 30.00% (Q1 FY27). FII holding down ~1.3 pp QoQ; no pledges or strategic moves flagged. Regulatory: No material compliance issues. M&A / Strategic: None reported.
What to Watch on October 29
1 · Revenue & growth rate
Print between ₹600–650 Cr confirms plan. Below ₹580 Cr is a miss (order delays or capacity constraints). Growth rate vs Q1's 28% will signal if momentum is sustaining or moderating — watch the commentary for demand outlook.
2 · EBITDA margin
19%+ is in-line; below 18% is weak (input costs, early-stage plant inefficiency, or unfavorable product mix). Management commentary on input-cost trajectory and Unit-III yield is critical. A guidance cut is a tail risk.
3 · Order book & pipeline
Confirm the industrial & renewable demand backdrop remains intact. Any caution on orders-in-hand or near-term enquiry pipeline would be a negative signal for FY27 guidance. CapEx plan update (additional allocations beyond the ₹90 Cr approved in Q1) could signal confidence.
4 · Unit-III ramp metrics
Expect first detailed commentary on the new plant: early yields, capacity utilization, and expected contribution by year-end. Any hint of execution risk (production delays, yield shortfalls, or unexpected capex overruns) will pressure the multiple.
Voltamp Transformers is at an inflection: a new 25+ MVA capacity facility just went live, revenue is growing 28% YoY, and the Street is broadly positive (Buy consensus, ~8–29% upside). But Q1 revealed margin pressure (operating profit growth lagging revenue sharply), raising questions about input-cost persistence and the new plant's early-stage profitability. Q2 FY27, printing exactly 22 days after Unit-III's start, is the litmus test. The market is pricing in steady execution; any slip on revenue growth, margin compression, or cautious unit-III commentary risks a sharp repricing.
Expect ₹600–650 Cr revenue, 18–19.5% EBITDA margin, and clear guidance on demand outlook and the new plant's ramp trajectory. A beat on margin would re-rate the stock higher; a miss could trigger a 10–15% correction.
Voltamp Q2 FY27: revenue jumps 42% YoY, but margin squeeze caps PAT growth at 8%
PAT +7.9% YoY · revenue +41.78% · margins compressing
₹684.19 Cr
+41.78% YoY
₹85.08 Cr
+7.9% YoY
12.29%
-3.6pp YoY
₹84.1
Voltamp Transformers posted standalone revenue of ₹684.19 Cr for Q2 FY27, up 41.8% year-on-year and 25.8% sequentially — its strongest quarterly top line in recent memory, reflecting faster execution of its order book. Net profit, however, rose only 7.9% YoY to ₹85.08 Cr and actually fell 6.7% quarter-on-quarter from Q1 FY27's ₹91.22 Cr, so the revenue strength did not carry through to the bottom line.
Q2 FY-2027 vs prior quarters
The gap is almost entirely a margin story. Net profit margin (PAT/total income) compressed to 12.3% from 15.85% a year ago and 15.58% in Q1. Core operating margin (PBT adjusted for other income, depreciation and finance costs, over revenue) fell to 15.46% from 19.39% YoY — though it improved from Q1's 14.77%. Net material cost (cost of materials net of inventory build) rose to 76.1% of revenue from 70.7% a year earlier, consistent with the input-cost pressure on the company's legacy fixed-price order book that PL Research flagged after a soft Q4 FY26 print and subsequent downgrade to Accumulate. The other swing factor was Other Income, which fell to ₹7.93 Cr from ₹41.61 Cr in Q1 and ₹14.76 Cr a year ago — per the cash-flow statement these are largely fair-value (FVTPL) gains on the investment book, which are lumpy quarter to quarter rather than a one-off exceptional item. A ₹6.09 Cr deferred tax credit held the effective tax rate to 22.3% (vs 24.3% a year ago), cushioning but not offsetting the hit.
The stock went into the print at ₹9,534, down 9.3% over the past month of trading.
For context: revenue is at a 6-quarter high.
There is no formal management guidance on record for this result, and no broker-consensus estimate specific to Q2 FY27 could be sourced, so both the vs-guidance and vs-street reads are unknown; FY27 full-year consensus (per public trackers) pegs EPS near ₹327, which H1 FY27's basic EPS of ₹174.26 is tracking toward only if H2 improves. On the ground, capex continued: capital work-in-progress rose to ₹171.6 Cr from ₹108.4 Cr at March 2026, and the company commenced production at its new EHV transformer plant in Vadodara on October 7, 2026 — a 6,000 MVA greenfield facility. No press release or management commentary accompanied this filing beyond the standard board-outcome letter, so there is no fresh company framing of the quarter to reconcile against the numbers.
W1
Whether input-cost pressure on the legacy fixed-price order book (~₹300 Cr per PL Research, expected to largely clear over 1-2 quarters) eases in H2 FY27.
W2
Whether the Q2 Other Income dip (₹7.93 Cr vs ₹41.61 Cr in Q1) was a one-quarter FVTPL mark-to-market swing or a lasting step-down.
W3
Margin contribution/dilution from the new Vadodara EHV facility (6,000 MVA capacity) as it ramps post its October 2026 commissioning.
Only standalone results filed (no consolidated statement, single-segment entity); unaudited, subject to limited review. All lines tie exactly (totalIncome = revenue + other income; PAT = PBT − tax). No separate exceptional-items line; a sharp Other Income swing (lumpy FVTPL mark-to-market gains) is the main driver of the gap between revenue and PAT growth.